Human papillomavirus (HPV) vaccine policy and evidence-based medicine: Are they at odds?

By Fastrez Maxime   Naik Haresh Nishan   Corfers Aurore   Rozenberg Serge  

Annals of Medicine, Vol. 44, Iss. 4, 2012-06 ,pp. : 404-404

Informa Healthcare

Access to resources Recommend Favorite

Risk, choice and the ‘girl vaccine’: Unpacking human papillomavirus (HPV) immunisation

By Mishra Amrita   Graham Janice E.  

Health, Risk & Society, Vol. 14, Iss. 1, 2012-02 ,pp. : 57-69

Routledge Ltd

Access to resources Recommend Favorite

HPV9 Vaccine for the Prevention of Human Papillomavirus–Related Cancers

By  

NURSING FOR WOMENS HEALTH, Vol. 19, Iss. 4, 2015-08 ,pp. : 365-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Focal epithelial hyperplasia by human papillomavirus (HPV)‐32 misdiagnosed as HPV‐16 and treated with combination of retinoids, imiquimod and quadrivalent HPV vaccine

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 12, 2015-12 ,pp. : 1172-1175

John Wiley & Sons Inc

Access to resources Recommend Favorite

Implementing an Evidence-Based Parenting Program in Community Agencies: What Helps and What Gets in the Way?

By Asgary-Eden Veronica  

Administration and Policy in Mental Health, Vol. 39, Iss. 6, 2012-11 ,pp. : 478-488

Springer Publishing Company

Access to resources Recommend Favorite